Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Baird Medical Investment Holdings (BDMDW) Receivables - Other (2023 - 2025)

Baird Medical Investment Holdings' quarterly Receivables - Other came in at $282025.0 in Q4 2025, down 17.36% year-on-year from $341288.0 in Q4 2024, and up 9571.64% quarter-over-quarter from $2916.0 in Q2 2025.

Baird Medical Investment Holdings has reported Receivables - Other for 3 years, with the latest figure at $282025.0 in Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Other fell 17.36% year-over-year to $282025.0; the trailing twelve-month figure through Dec 2025 stood at $282025.0 (down 17.36% YoY), and the FY2025 full-year result was $282025.0, changed N/A from the prior year.
  • Receivables - Other for Q4 2025 stood at $282025.0, up from $2916.0 in the prior quarter.
  • The five-year high for Receivables - Other was $394582.0 in Q4 2023, with the low at $2916.0 in Q2 2025.
  • Average Receivables - Other over 3 years is $255202.8, with a median of $311656.5 recorded in 2024.
  • Year-over-year, Receivables - Other fell 13.51% in 2024 and decreased 17.36% in 2025.
  • Tracing BDMDW's Receivables - Other over 3 years: stood at $394582.0 in 2023, then slipped by 13.51% to $341288.0 in 2024, then declined by 17.36% to $282025.0 in 2025.
  • The last three Receivables - Other figures came in at $282025.0 (Q4 2025), $2916.0 (Q2 2025), and $341288.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Baird Medical Investment Holdings - - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 282,025.00
Dec 31, 2025 282,025.00
Jun 30, 2025 2,916.00
Jun 30, 2025 2,916.00
Dec 31, 2024 341,288.00
Dec 31, 2024 341,288.00
Dec 31, 2023 394,582.00
Dec 31, 2023 394,582.00